April 22, 2025 8:33 View More The Shocking Truth About Bone Loss How to Rebuild Strength with Kevin Ellis, The Bone Coach In this podcast episode, host McCall McPherson engages with Kevin Ellis, "The Bone Coach," who shares his journey from a Marine to a bone health advocate after being diagnosed with osteoporosis at a young age
Additionally, per publicly available FDA and manufacturer announcements, orforglipron (Eli Lilly's Foundayo, a non-peptide oral GLP-1 receptor agonist) received FDA approval on April 1, 2026 for chronic weight management
Weight regain is visible, the metabolic reversal is not. CNBC reported that GLP1s are practically everywhere roughly 1 in 8 US adults take one, and that discontinuation rates run as high as 36 percent to 81 percent in several studies, driven by access challenges and side effects such as nausea and vomiting
The mechanism stems from semaglutide's effect on stomach-to-intestine transit time, which shortens the window for iron absorption in the upper digestive tract
If your doctor is using these tests to adjust your medication dosage, a biotin-heavy supplement could lead to an incorrect prescription
Follow the standard retatrutide starting dose protocol with escalation every 4 weeks
